James G Barbee
Overview
Explore the profile of James G Barbee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papakostas G, Shelton R, Zajecka J, Etemad B, Rickels K, Clain A, et al.
Am J Psychiatry
. 2012 Dec;
169(12):1267-74.
PMID: 23212058
Objective: The authors conducted two multicenter sequential parallel comparison design trials to investigate the effect of L-methylfolate augmentation in the treatment of major depressive disorder in patients who had a...
2.
Barbee J, Thompson T, Jamhour N, Stewart J, Conrad E, Reimherr F, et al.
J Clin Psychiatry
. 2011 Mar;
72(10):1405-12.
PMID: 21367355
Background: Previous reports have suggested that lamotrigine is effective as an antidepressant augmentation agent in patients with treatment-resistant unipolar depression. This study is the largest double-blind placebo-controlled study conducted to...
3.
4.
Barbee J, Conrad E, Jamhour N
Ann Clin Psychiatry
. 2005 Feb;
16(4):189-94.
PMID: 15702566
Background: Evidence is accumulating to support the use of atypical neuroleptics as adjunctive treatment for refractory mood disorders, although there are currently no published data on the efficacy of an...
5.
Barbee J, Conrad E, Jamhour N
J Clin Psychiatry
. 2004 Aug;
65(7):975-81.
PMID: 15291687
Background: Many questions remain regarding the use of atypical neuroleptics as antidepressant augmentation agents. To date, there have been no reports in the literature regarding the effectiveness of these drugs...
6.
Barbee J
Int J Eat Disord
. 2003 Mar;
33(4):468-72.
PMID: 12658677
Objective: To report observations on the efficacy and tolerability of topiramate in a sample of five patients with severe symptoms of bulimia nervosa and comorbid mood and/or anxiety disorders. Method:...
7.
Barbee J, Billings C, Bologna N, Townsend M
J Affect Disord
. 2003 Jan;
73(3):229-36.
PMID: 12547291
Objective: The authors examined the long-term outcome of generalized anxiety disorder with depressive symptoms utilizing both categorical and dimensional analyses. Method: Thirty-nine out-patients with a DSM-III-R diagnosis of generalized anxiety...
8.
Constans J, Barbee J, Townsend M, Leffler H
J Anxiety Disord
. 2002 Sep;
16(3):311-9.
PMID: 12214816
The stability of worry content was investigated in a sample of 27 individuals diagnosed with Generalized Anxiety Disorder. During an initial evaluation, participants were asked to describe the content of...
9.
Barbee J, Jamhour N
J Clin Psychiatry
. 2002 Aug;
63(8):737-41.
PMID: 12197456
Background: The anticonvulsant lamotrigine has been reported to be efficacious and well tolerated as monotherapy in the treatment of bipolar patients as well as in treatment-refractory bipolar disorder. However, there...